Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Biofilm matrix components collectively refer to the network of extracellular polymeric substances (EPS), including polysaccharides, proteins, nucleic acids, and lipids, secreted by microorganisms within the biofilm. These components create a complex, protective scaffold that supports biofilm structure, mediates adhesion to surfaces, and shields bacteria from antibiotics and immune responses[1][3][5][7]. Therapeutic targeting of the biofilm matrix often involves metal ion chelation—using agents such as EDTA or citrate—to disrupt essential ionic cross-links (especially divalent cations like calcium and magnesium) that stabilize the matrix[2][4][8]. Other agents, including poloxamers and glycerol, may disrupt the matrix physically or chemically. This approach is used to destabilize mature biofilms, enhance antimicrobial efficacy, and combat chronic or device-associated infections[2][4][6].
Metal ion chelation (removal of stabilizing cations); Physical disruption of matrix; Enhanced penetration of antimicrobials; Destabilization of matrix cohesion
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biofilm matrix component.